-transparent.png){kind=logo}
1,1'-Ethylene-bis(1-nitrosourea) (EBNU) posesses antitumor activity against leukemia L-1210. Chemical stability, alkylating activity, and lipophilicity of EBNU and related compounds were compared. EBNU was the most unstable among several bis-N-nitrosoureas and mono-N-nitrosoureas tested. The alkylating activity of EBNU was the same as that of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), but higher than those of other bis- and mono-N-nitrosoureas except 1-methyl-1-nitrosourea. Lipophilicity of EBNU was extremely low compared with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and CCNU.
Related Publications
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
March 1967,
Journal of medicinal chemistry,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
October 1977,
Gan,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
July 1967,
Journal of medicinal chemistry,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
August 1974,
Cancer research,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
January 1985,
International journal of immunopharmacology,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
May 2001,
Die Pharmazie,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
September 1989,
Cancer research,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
March 1967,
Cancer research,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
July 1965,
Applied microbiology,
K Morimoto, and
T Yamaha, and
M Nakadate, and
I Suzuki
June 1995,
Journal of medicinal chemistry,
